相关实验视频

Updated: Jun 13, 2025

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

在多发性硬化症中基于MiRNA的治疗潜力

Ana Zabalza¹, Agustin Pappolla¹, Manuel Comabella¹

¹Vall Hebron University Hospital & Research Institute (VHIR), Multiple Sclerosis Centre of Catalonia (Cemcat) & Neurology Department, Universitat Autonoma de Barcelona, Barcelona, Spain.

Frontiers in immunology

|September 13, 2024

概括

微RNAs (miRNAs) 是多发性硬化症 (MS) 病原和结果的关键参与者. 本综述探讨了它们的诊断潜力和MS的治疗应用.

科学领域:

神经科学是一个神经科学.
分子生物学分子生物学
遗传学遗传学是一个

背景情况:

多发性硬化症 (MS) 是一种慢性自身免疫性疾病,影响中枢神经系统.
目前对MS病理生理学,生物标志物和治疗方法的理解正在不断发展.
微RNA (miRNA) 是小的非编码RNA,在基因表达中起着重要的调节作用.

研究的目的:

审查微RNAs (miRNAs) 在多发性硬化症 (MS) 和其临床结果中的作用.
探索miRNAs作为MS诊断和预后生物标志物的潜力.
讨论目前和新兴的基于miRNA的MS治疗策略.

主要方法:

在MS中调查miRNA的研究的文献综述.
在生物流体 (血清,血,脑脊液) 中分析miRNA表达.
基于miRNA的治疗方法的概述,包括恢复和抑制.

主要成果:

特定的miRNAs在MS的各种临床形式中被差异地表达.
在MS中,miRNA显示出作为诊断和预后生物标志物的潜力.
目前正在开发各种基于miRNA的治疗策略来治疗MS.

结论:

miRNAs代表了多发性硬化症 (MS) 的有希望的治疗标和生物标志物.
需要进一步的研究来验证治疗疗效,并优化基于miRNA的治疗的输送方法.
解决交付和验证方面的局限性对于推进MS的miRNA疗法至关重要.

关键词:

生物标志物生物标志物微RNAs 是一个微型RNA.多发性硬化症多发性硬化症神经学神经学神经学治疗目标是治疗的目标.

更多相关视频

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA

Published on: December 26, 2015

相关概念视频

siRNA - Small Interfering RNAs

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...